Literature DB >> 1883324

Dexamethasone inhibits the hexose monophosphate shunt in activated rat peritoneal macrophages by reducing hexokinase-dependent sugar uptake.

R J Rist1, R J Naftalin.   

Abstract

Dexamethasone decreases 2-D-deoxyglucose (2-dGlc) uptake and accumulation into rat peritoneal macrophages in vitro in a concentration- and time-dependent manner (Ki for 1 microM-dexamethasone after a 2 h exposure = 0.71 +/- 0.21 microM; Ki for 0.1 microM-dexamethasone after exposure for 4 h = 0.10 +/- 0.06 microM). The inhibition of 2-dGlc uptake is consistent with a decrease in the coupling between endofacial hexokinase activity and the sugar transporter. The evidence for this is: (1) the Km for zero-trans 2-dGlc uptake in quiescent macrophages was increased by dexamethasone, but there was no significant effect on the Vmax.; (2) dexamethasone increased the rate of exit of sugar from cells preloaded with 2-dGlc; (3). the free sugar accumulation within the cytosol of the cells above the external solution concentration was significantly decreased by dexamethasone. These effects of dexamethasone on 2-dGlc transport were antagonized by simultaneous exposure to the steroid RU 38486 (Ki = 0.04 +/- 0.01 microM; 4 h incubation). Although dexamethasone inhibited zero-trans uptake, the maximum rate of infinite-trans exchange uptake of 2-dGlc into cells preloaded with 3-O-methyl-D-glucose (40 mM) was unaltered by dexamethasone or RU 38486, indicating that the dexamethasone-dependent decrease in zero-trans uptake was not due to a change in the number of transporters in the plasma membrane. Dexamethasone also inhibited the phorbol myristate acetate-induced stimulation of hexose monophosphate shunt (HMPS) activity, and this was reversed by RU 38486. Cytochalasin B, the potent sugar-transport inhibitor, inhibited HMPS activity and 2-d[2,6-3H]Glc uptake equally, indicating a single site of action. By contrast, dexamethasone showed differential inhibition of HMPS activity and 2-d[2,6-3H]Glc uptake, suggesting that it not only acts by decreasing the coupling between hexokinase and sugar transport, but also at one or more additional points.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883324      PMCID: PMC1151458          DOI: 10.1042/bj2780129

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  EFFECT OF GLUCOCORTICOIDS IN VIVO AND IN VITRO ON NET GLUCOSE UPTAKE AND AMINO ACID INCORPORATION BY RAT-THYMUS CELLS.

Authors:  Y MORITA; A MUNCK
Journal:  Biochim Biophys Acta       Date:  1964-10-09

2.  Dexamethasone causes translocation of glucose transporters from the plasma membrane to an intracellular site in human fibroblasts.

Authors:  H C Horner; A Munck; G E Lienhard
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

3.  A model for accelerated uptake and accumulation of sugars arising from phosphorylation at the inner surface of the cell membrane.

Authors:  R J Naftalin; P M Smith
Journal:  Biochim Biophys Acta       Date:  1987-02-12

4.  Corynebacterium parvum-elicited hepatic macrophages demonstrate enhanced respiratory burst activity compared with resident Kupffer cells in the rat.

Authors:  M J Arthur; P Kowalski-Saunders; R Wright
Journal:  Gastroenterology       Date:  1986-07       Impact factor: 22.682

5.  Effect of endotoxin on release of reactive oxygen intermediates by rat hepatic macrophages.

Authors:  M J Arthur; P Kowalski-Saunders; R Wright
Journal:  Gastroenterology       Date:  1988-12       Impact factor: 22.682

6.  Interaction of steroids with the transport system of glucose in human erythrocytes.

Authors:  L Lacko; B Wittke; P Geck
Journal:  J Cell Physiol       Date:  1975-12       Impact factor: 6.384

7.  Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages.

Authors:  I Maridonneau-Parini; M Errasfa; F Russo-Marie
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

8.  Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages.

Authors:  P Newsholme; R Curi; S Gordon; E A Newsholme
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

9.  Effects of various inhibitors of arachidonic acid oxygenation on macrophage superoxide release and tumoricidal activity.

Authors:  R M Schultz; S K Nanda; M G Altom
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

10.  Inhibition of macrophage tumoricidal activity by glucocorticoids.

Authors:  M M Hogan; S N Vogel
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

View more
  4 in total

1.  Hexokinase II binding to mitochondria is necessary for Kupffer cell activation and is potentiated by ethanol exposure.

Authors:  Nataly Shulga; John G Pastorino
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

2.  The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.

Authors:  Azadeh Ahmadian; Sumeet Pawar; Praveen Govender; Jeffrey Berman; Frederick L Ruberg; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2016-07-25       Impact factor: 5.952

3.  Glucose- and phorbol myristate acetate-stimulated oxygen consumption and superoxide production in rat peritoneal macrophages is inhibited by dexamethasone.

Authors:  R J Rist; R J Naftalin
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

4.  RP 54745, a potential antirheumatic compound. I. Inhibitor of macrophage stimulation and interleukin-1 production.

Authors:  F Folliard; A Bousseau; B Terlain
Journal:  Agents Actions       Date:  1992-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.